Home Revisiting The Investment Case On Progenics Pharmaceuticals
 

Keywords :   


Revisiting The Investment Case On Progenics Pharmaceuticals

2015-06-14 14:46:06| Biotech - Topix.net

The stock of small biotech Progenics Pharmaceuticals has been on the move since I last profiled the company over a month ago. The company recently got approved by the European Commission to expand distribution of its lead product and this should boost sales in the years ahead.

Tags: case investment pharmaceuticals revisiting

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
09.10Hurricane Milton Public Advisory Number 18A
09.10Atlantic Tropical Weather Outlook
09.10Eastern North Pacific Tropical Weather Outlook
09.10Schreiner Group names Ken Forlenza US president
09.10Intake variation affects performance and feed efficiency of finishing beef cattle
09.10Hurricane Milton Update Statement
09.10Summary for Hurricane Milton (AT4/AL142024)
09.10INX earns Great Place to Work recertification
More »